For people who have heart disease, statins are great. But if all you've had is high cholesterol, what you're doing is taking this 1/100 chance of getting a benefit and offsetting it with 1/200 chance of getting diabetes.

Not only can consumers handle their personal genetic information, but they are getting genomically oriented and anchored about such data.

It's infrequent that people are rail thin yet have high blood pressure.

The ability to diagnose an imminent heart attack has long been considered the holy grail of cardiovascular medicine.

A lot of the diagnosis and monitoring functions will be done through little devices - smartphones - by the patient with computer assistance. So it's a real big change in the model of how we render healthcare.

About half of all people don't take medications like they're supposed to.

Medicine is still all about treating populations, not people - one-size-fits all treatments and diagnoses.